Leboulleux S, Benisvy D, Taieb D, Attard M, et al. MERAIODE: A Phase II Redifferentiation Trial with Trametinib and 131I in Metastatic Radioactive Iodine Refractory RAS Mutated Differentiated thyroid Cancer. Thyroid 2023 Jun 23. doi: 10.1089/thy.2023.0240.
PMID: 37350119